MRSN - Mersana Therapeutics, Inc. - SEC Form 4 Insider Trading Screener
5 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-03-05 | MRSN | Mott David M | Dir, 10% | P - Purchase | $4.00 | +3,750,000 | 11,890,138 | +46% | +$15,000,000 | ||||||
2019-03-05 | MRSN | New Enterprise Associates 14, L.P. | 10% | P - Purchase | $4.00 | +3,750,000 | 11,890,138 | +46% | +$15,000,000 | ||||||
| D | 2018-09-24 | MRSN | Lowinger Timothy B | Chief Scientific Officer | S - Sale+OE | $11.63 | -3,500 | 12,491 | -22% | -$40,705 | |||||
| D | 2018-08-27 | MRSN | Lowinger Timothy B | Chief Scientific Officer | S - Sale+OE | $13.15 | -3,500 | 12,491 | -22% | -$46,025 | |||||
2018-07-23 | MRSN | Lowinger Timothy B | Chief Scientific Officer | S - Sale | $11.06 | -3,500 | 12,491 | -22% | -$38,710 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |